The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (14 analysts) rates it hold, with a mean price target of $29.
Olin Corporation OLN
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, the Middle East, Africa, and India Middle East, Africa, India, Latin America, and Canada.
read at $18.59
Olin Corporation holds its Distribution at $18.59.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 3 days |
| Price | $18.59 |
| Valuation | N/A trailing · 23.52 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.20 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | -0.90% |
| Profit margin | -2.94% |
| Debt to equity | 199.06 |
| Analyst consensus | Hold · 13 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its debt ratio. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is 42.9% of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 12.7% of assets, under the 49% limit. Pass
- Revenue purity Only 0.1% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Chemical maker caught in a value trap
Picture a chlorine plant running flat out one year and idling the next when construction and autos slow. Olin sits in that exact spot. Revenue is already shrinking four percent, margins have flipped negative and return on equity sits at minus ten percent. The shares trade at twenty two dollars against a fair value nearer fifteen, so investors are paying a premium for a business that is contracting, not expanding.
The forward multiple of twenty three times earnings looks reasonable only if you ignore the cycle. In chemicals, peak margins often coincide with the lowest multiples, and this looks like one of those moments. Analysts call it a hold with a twenty five dollar median target, yet the underlying numbers show no moat and no growth to support that price.
Ethical checks clear, yet the cyclical trap remains. Earnings can collapse fast when demand fades, and a low multiple at the top of the cycle is rarely a bargain. The margin of safety sits thirty percent the wrong way. Analysis, not advice.
| Forward P/E | 23.5x a premium valuation |
| Revenue growth | -0.9% revenue is shrinking |
| Profit margin | -2.9% currently unprofitable |
| Return on equity | -10.6% not currently earning a positive return on equity |
| Debt to equity | 1.99 a meaningful debt load worth watching |
| Current ratio | 1.42 adequate liquidity, worth monitoring |
| Beta | 1.20 moves a little more than the market |
| Market cap | $2.1B |
| Employees | 7,849 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in OLN's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
OLN trades on the NYSE. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (14 analysts) rates it hold, with a mean price target of $29.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-10 | Richard Blumenthal | Democrat | Purchase | 1K–15K |
| 10 Apr2026 | Richard Blumenthal | Democrat | buy | 1K–15K |
| 10 Apr2026 | Richard Blumenthal | Democrat | buy | 1K–15K |
| 10 Apr2026 | Richard Blumenthal | Democrat | buy | 1K–15K |
| 10 Apr2026 | Richard Blumenthal | Democrat | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $28.22 | -15.3% | $0.20 | $854 | -14.6% |
| 2 months | $28.75 | -16.8% | $0.20 | $839 | -16.1% |
| 3 months | $25.83 | -7.4% | $0.20 | $934 | -6.6% |
| 6 months | $21.99 | +8.7% | $0.40 | $1,106 | +10.6% |
| 1 year | $21.21 | +12.7% | $0.80 | $1,165 | +16.5% |
| 2 years | $47.27 | -49.4% | $1.60 | $540 | -46.0% |
| 3 years | $47.78 | -50.0% | $2.40 | $551 | -44.9% |
| 5 years | $43.99 | -45.7% | $4.00 | $634 | -36.6% |
Historical returns from market close data. Past performance does not guarantee future results.